Clinical Trials
The UK Gene-Editing Trial Map for 2026: Five Programmes, Honest Timelines and Questions Patients Should Ask
A patient-focused guide to five gene-editing programmes with UK links in 2026, from blood disorders to liver and metabolic disease. It explains how NHS and private access differ, what trial phases really mean, and how to separate realistic hope from marketing hype.